magnesium sulfate kalceks 200 mg/ml injekčný/infúzny roztok
as kalceks, lotyšsko - síran horečnatý - 39 - soli a ionty pro p.o. a parent. aplikÁciu
magnesium sulfate kalceks 100 mg/ml injekčný/infúzny roztok
as kalceks, lotyšsko - síran horečnatý - 39 - soli a ionty pro p.o. a parent. aplikÁciu
cresemba
basilea pharmaceutica deutschland gmbh - isavuconazole - aspergilóza - cresemba je indikovaný u dospelých na liečbu:invázne aspergillosismucormycosis u pacientov, pre ktorých amphotericin b je inappropriateconsideration by mala byť oficiálne usmernenie o vhodnom používaní protiplesňové agentov.
ampicilín/sulbaktám aptapharma 2 g/1 g prášok na injekčný/infúzny roztok
apta medica internacional d.o.o., slovinsko - ampicilín a inhibítor betalaktamázy - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
ampicilín/sulbaktám aptapharma 1 g/0,5 g prášok na injekčný/infúzny roztok
apta medica internacional d.o.o., slovinsko - ampicilín a inhibítor betalaktamázy - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
piperacillin/tazobactam kabi 2 g/0,25 g
fresenius kabi s.r.o., Česká republika - piperacilín a inhibítor betalaktamázy - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
piperacillin/tazobactam kabi 4 g/0,5 g
fresenius kabi s.r.o., Česká republika - piperacilín a inhibítor betalaktamázy - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
pifeltro
merck sharp & dohme b.v. - doravirine - hiv infekcie - antivirotiká na systémové použitie - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.
delstrigo
merck sharp & dohme b.v. - doravirine, lamivudine, tenofovir disoproxil fumarate - hiv infekcie - antivirotiká na liečbu infekcií hiv, kombinácie - delstrigo je indikovaný na liečbu dospelých infikovaných hiv-1 bez minulosti, alebo predložiť dôkaz, odolnosť voči nnrti triedy, lamivudine, alebo tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastické činidlá - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).